SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Price to free cash flow ratio
Latest
-1.58
↑ 96% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-35.67
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -1.58 | -55.9% |
| 2024 | -1.01 | +32.4% |
| 2023 | -1.50 | -49.8% |
| 2022 | -1.00 | +97.4% |
| 2021 | -37.90 | +76.6% |
| 2020 | -161.80 | -260.2% |
| 2019 | -44.92 | - |